ArticleClinical & experimental metastasis2022

Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.

Ciro Franzese et al.PubMed ↗Publisher ↗

No numbers read from the abstract.